Akero Therapeutics
AKRO
$19.66
Share price
-0.25%
Change (1 day)
-55.25%
Change (1 year)
Categories
Akero Therapeutics (AKRO) - P/B ratio
P/B ratio as of May 2024 : 2.55
According to Akero Therapeutics's latest financial reports the company has a price-to-book ratio of 2.55.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Akero Therapeutics - P/B ratio (from 2019 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.43 | -69.03% |
| 2022-12-31 | 7.85 | 79.78% |
| 2021-12-31 | 4.36 | 25.99% |
| 2020-12-31 | 3.46 | -29.66% |
| 2019-12-31 | 4.93 | |
| 2018-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.86 | 12.50% | 🇺🇸 USA |